Analytical Data
-
基因名
PRDM2
- Application
-
别名
PRDM2；KMT8；RIZ；PR domain zinc finger Protein 2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q13029
-
表达区间
全长
-
氨基酸序列
full
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human RBM6 Protein，GST
Cat：PAX2000-10810
Recombinant E.coli tktA Protein，His
Cat：PA2000-2667
Protein Description
PRDM2, also known as PRDI-BF1 (Positive Regulatory Domain I-Binding Factor 1), is a member of the PRDM (PRDI-BF1 and RIZ1 homologous domain) family of proteins that play critical roles in various biological processes, including gene regulation, cellular differentiation, and development. PRDM2 functions as a transcriptional regulator, influencing the expression of numerous genes involved in immune responses and tumor suppression. Dysregulation of PRDM2 has been implicated in several types of cancer, making it a significant focus for research aimed at understanding its role in tumor biology. Specifically, the study of PRDM2 recombinant proteins allows scientists to investigate the structure-function relationships of this protein, enabling insights into its interactions with DNA and other cellular partners. These studies can provide valuable information about its regulatory mechanisms, potential as a therapeutic target, and its involvement in disease states. As recombinant technology advances, generating PRDM2 proteins for detailed biochemical analysis and functional assays becomes more accessible, paving the way for innovative approaches in cancer therapy and other fields. This research underscores the importance of PRDM2 in maintaining cellular homeostasis and its potential as a biomarker for disease progression.
